These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1145 related articles for article (PubMed ID: 23887658)

  • 1. Long non-coding RNAs in haematological malignancies.
    Garitano-Trojaola A; Agirre X; Prósper F; Fortes P
    Int J Mol Sci; 2013 Jul; 14(8):15386-422. PubMed ID: 23887658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNAs in normal and malignant hematopoiesis.
    Nobili L; Lionetti M; Neri A
    Oncotarget; 2016 Aug; 7(31):50666-50681. PubMed ID: 27177333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of long non-coding RNAs in normal and malignant hematopoiesis.
    Wei P; Han B; Chen Y
    Sci China Life Sci; 2013 Oct; 56(10):867-75. PubMed ID: 24030284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multifactorial role of long non-coding RNAs (LncRNAs) in hematopoiesis.
    Khawar MB; Mehmood R; Abbasi MH; Sheikh N
    Front Biosci (Schol Ed); 2018 Jan; 10(1):119-126. PubMed ID: 28930521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long noncoding RNAs: new insights into non-small cell lung cancer biology, diagnosis and therapy.
    Ricciuti B; Mencaroni C; Paglialunga L; Paciullo F; Crinò L; Chiari R; Metro G
    Med Oncol; 2016 Feb; 33(2):18. PubMed ID: 26786153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging mechanisms of long noncoding RNA function during normal and malignant hematopoiesis.
    Alvarez-Dominguez JR; Lodish HF
    Blood; 2017 Nov; 130(18):1965-1975. PubMed ID: 28928124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNAs: emerging regulators of normal and malignant hematopoiesis.
    Qiu Y; Xu M; Huang S
    Blood; 2021 Dec; 138(23):2327-2336. PubMed ID: 34482397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Coding and Long Noncoding RNAs Differentially Expressed in Tumors and Preferentially Expressed in Healthy Tissues.
    Unfried JP; Serrano G; Suárez B; Sangro P; Ferretti V; Prior C; Boix L; Bruix J; Sangro B; Segura V; Fortes P
    Cancer Res; 2019 Oct; 79(20):5167-5180. PubMed ID: 31387921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNAs and MYC association in hematological malignancies.
    Benetatos L; Benetatou A; Vartholomatos G
    Ann Hematol; 2020 Oct; 99(10):2231-2242. PubMed ID: 32621182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic, prognostic and therapeutic potential of long noncoding RNAs in cancer.
    Khawar MB; Hamid SE; Jan T; Abbasi MH; Idnan M; Sheikh N
    Mol Biol Rep; 2022 Mar; 49(3):2311-2319. PubMed ID: 35072835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNAs in hematopoietic malignancies.
    Rodríguez-Malavé NI; Rao DS
    Brief Funct Genomics; 2016 May; 15(3):227-38. PubMed ID: 26612601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNAs during normal and malignant hematopoiesis.
    Alvarez-Dominguez JR; Hu W; Gromatzky AA; Lodish HF
    Int J Hematol; 2014; 99(5):531-41. PubMed ID: 24609766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging role of long non-coding RNAs in normal and malignant hematopoiesis.
    Wang FY; Gu ZY; Gao CJ
    Chin Med J (Engl); 2020 Feb; 133(4):462-473. PubMed ID: 31904731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression profiles of long non-coding RNAs reveal potential biomarkers for identification of human gastric cancer.
    Li C; Liang G; Yao W; Sui J; Shen X; Zhang Y; Ma S; Ye Y; Zhang Z; Zhang W; Yin L; Pu Y
    Oncol Rep; 2016 Mar; 35(3):1529-40. PubMed ID: 26718650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TUG1: a pivotal oncogenic long non-coding RNA of human cancers.
    Li Z; Shen J; Chan MT; Wu WK
    Cell Prolif; 2016 Aug; 49(4):471-5. PubMed ID: 27339553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of long non-coding RNAs in hematologic malignancies].
    Hu WL; Gao A
    Yi Chuan; 2015 Nov; 37(11):1095-104. PubMed ID: 26582523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging concepts of epigenetic dysregulation in hematological malignancies.
    Ntziachristos P; Abdel-Wahab O; Aifantis I
    Nat Immunol; 2016 Sep; 17(9):1016-24. PubMed ID: 27478938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A brief review on long noncoding RNAs: a new paradigm in breast cancer pathogenesis, diagnosis and therapy.
    Malih S; Saidijam M; Malih N
    Tumour Biol; 2016 Feb; 37(2):1479-85. PubMed ID: 26662315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNAs in hematological malignancies: translating basic techniques into diagnostic and therapeutic strategies.
    Wong NK; Huang CL; Islam R; Yip SP
    J Hematol Oncol; 2018 Nov; 11(1):131. PubMed ID: 30466456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA: Classification, biogenesis and functions in blood cells.
    Dahariya S; Paddibhatla I; Kumar S; Raghuwanshi S; Pallepati A; Gutti RK
    Mol Immunol; 2019 Aug; 112():82-92. PubMed ID: 31079005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 58.